PE20020269A1 - Derivados de pirrol como inhibidores de transcriptasa inversa del vih - Google Patents

Derivados de pirrol como inhibidores de transcriptasa inversa del vih

Info

Publication number
PE20020269A1
PE20020269A1 PE2001000487A PE2001000487A PE20020269A1 PE 20020269 A1 PE20020269 A1 PE 20020269A1 PE 2001000487 A PE2001000487 A PE 2001000487A PE 2001000487 A PE2001000487 A PE 2001000487A PE 20020269 A1 PE20020269 A1 PE 20020269A1
Authority
PE
Peru
Prior art keywords
alkyl
methyl
aryl
inhibitors
reverse transcriptase
Prior art date
Application number
PE2001000487A
Other languages
English (en)
Inventor
Philip Stephen Jones
Brian William Dymock
John Herbert Merrett
Martin John Parratt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20020269A1 publication Critical patent/PE20020269A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE PIRROL DE FORMULA I DONDE R1 Y R2 SON ALQUILO, CICLOALQUILO, ARILO, HETEROCICLO; R3 ES H, ALQUILO, CICLOALQUILO, ARILO, HETEROCICLO; R4 ES H, ALQUILO, CARBOXILO, C=OR, CONR'R'", CN, ALQUENILO; R ES H, ALQUILO, ALCOXILO, TRIFLUOROMETILO, METIL-OXI-CARBONILO, ETIL-OXI-CARBONILO; R' Y R" SON H, ALQUILO, ARILO; R5 ES ALQUILO, ARILO, Z-C(=O)R"'; Z ES ENLACE, HC=CH; R2'" ES H, ALQUILO; X ES S, SO, SO2, N-ALQUILO; X-R2 EN CONJUNTO ES CH2-ARILO, CH2-HETEROCICLO; UNO DE R3 Y R4 ES H Y ALQUILO EN R3 NO ES CF3. SON COMPUESTOS PREFERIDOS 5-(3,5-DICLOROFENIL-TIO)-4-ISOPROPIL-2-METIL-1-[(3-PIRIDIL)METIL]-1H-PIRROL-3-METANOL, 4-ISOPROPIL-2-METIL-5-FENILTIO-1-[(4-PIRIDIL)-METIL]-1H-PIRROL-3-METANOL, ENTRE OTROS, TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION Y A COMPUESTOS INTERMEDIOS. LOS COMPUESTOS SON INHIBIDORES DE LA ENZIMA TRANSCRIPTASA INVERSA Y PUEDE SER UTIL PARA EL TRATAMIENTO EL VIH.
PE2001000487A 2000-07-04 2001-05-25 Derivados de pirrol como inhibidores de transcriptasa inversa del vih PE20020269A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016453.3A GB0016453D0 (en) 2000-07-04 2000-07-04 Pyrrole derivatives

Publications (1)

Publication Number Publication Date
PE20020269A1 true PE20020269A1 (es) 2002-04-08

Family

ID=9895031

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000487A PE20020269A1 (es) 2000-07-04 2001-05-25 Derivados de pirrol como inhibidores de transcriptasa inversa del vih

Country Status (17)

Country Link
US (1) US6737429B2 (es)
EP (1) EP1301481A1 (es)
JP (1) JP2004502674A (es)
KR (1) KR100549884B1 (es)
CN (1) CN1440385A (es)
AR (1) AR028602A1 (es)
AU (2) AU6387401A (es)
BR (1) BR0112241A (es)
CA (1) CA2412270A1 (es)
EC (1) ECSP014109A (es)
GB (1) GB0016453D0 (es)
GT (1) GT200100111A (es)
MX (1) MXPA02012409A (es)
PA (1) PA8516201A1 (es)
PE (1) PE20020269A1 (es)
UY (1) UY26720A1 (es)
WO (1) WO2002002524A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405849A1 (en) * 2002-10-04 2004-04-07 Corning Incorporated Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
KR101122708B1 (ko) * 2003-12-26 2012-03-26 마사토시 하기와라 Ｓｒ 단백질 인산화 제어 방법, 및 유효성분으로서 ｓｒ 단백질 활성 제어제를 함유하는 항바이러스제
JP5173192B2 (ja) 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
TW200628446A (en) * 2004-12-14 2006-08-16 Takeda Pharmaceuticals Co Substituted pyrrole derivative
EP1838679A1 (en) * 2005-01-06 2007-10-03 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
US7977488B2 (en) 2005-08-30 2011-07-12 Takeda Pharmaceutical Company Limited 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
WO2008054605A2 (en) * 2006-10-06 2008-05-08 Merck & Co., Inc. Non-nucleoside reverse transcriptase inhibitors
EP2099443A4 (en) * 2006-11-10 2010-05-05 Syndax Pharmaceuticals Inc ASSOCIATION OF ERA + LIGANDS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2009015180A2 (en) * 2007-07-23 2009-01-29 Syndax Pharmaceuticals, Inc. Novel compounds and methods of using them
KR101546987B1 (ko) * 2007-10-16 2015-08-24 가부시키가이샤 니콘 조명 광학 시스템, 노광 장치 및 디바이스 제조 방법
US20090131367A1 (en) * 2007-11-19 2009-05-21 The Regents Of The University Of Colorado Combinations of HDAC Inhibitors and Proteasome Inhibitors
NZ591793A (en) 2008-08-27 2012-11-30 Takeda Pharmaceutical Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds
GB0823001D0 (en) * 2008-12-17 2009-01-28 Syngenta Participations Ag Thiophene,furan and pyrrole derivatives with plant growth regulating properties
CN101775011B (zh) * 2009-01-13 2013-07-31 中国人民解放军军事医学科学院毒物药物研究所 N-取代苯基-3-甲烯杂环芳烃-2,5-二甲基吡咯类化合物及其抗hiv/aids的应用
EP4061360A4 (en) * 2019-11-19 2023-07-05 New York Blood Center, Inc. SUBSTITUTED HETEROCYCLIC COMPOUNDS SHOWING THERAPEUTIC ACTIVITY AGAINST HIV

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644631A (en) * 1969-05-13 1972-02-22 Endo Lab Therapeutic methods utilizing aryl pyrrol-3-yl ketones
US4282242A (en) * 1980-03-07 1981-08-04 Pfizer Inc. Antidiabetic pyrrolecarboxylic acids
US4347186A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
DK0674631T3 (da) * 1992-12-17 2000-04-10 Pfizer Substituerede pyrazoler som CRF-antogonister
US5968944A (en) * 1994-06-06 1999-10-19 Pfizer Inc. Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
US6417202B1 (en) * 1996-07-11 2002-07-09 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin-and TNF antagonists
DE19963174A1 (de) * 1999-12-27 2001-07-12 Gruenenthal Gmbh Substituierte Pyrrol-Mannichbasen

Also Published As

Publication number Publication date
GB0016453D0 (en) 2000-08-23
UY26720A1 (es) 2001-11-30
CA2412270A1 (en) 2002-01-10
US20020032221A1 (en) 2002-03-14
AU2001263874B2 (en) 2006-10-19
KR100549884B1 (ko) 2006-02-06
WO2002002524A1 (en) 2002-01-10
AR028602A1 (es) 2003-05-14
GT200100111A (es) 2002-03-18
US6737429B2 (en) 2004-05-18
AU6387401A (en) 2002-01-14
MXPA02012409A (es) 2003-04-25
CN1440385A (zh) 2003-09-03
BR0112241A (pt) 2003-06-24
KR20030014321A (ko) 2003-02-15
EP1301481A1 (en) 2003-04-16
ECSP014109A (es) 2002-02-25
PA8516201A1 (es) 2002-07-30
JP2004502674A (ja) 2004-01-29

Similar Documents

Publication Publication Date Title
PE20020269A1 (es) Derivados de pirrol como inhibidores de transcriptasa inversa del vih
TR200401772T4 (tr) hPPAR alfa aktivatörleri olarak ikame edilmiş oksazol ve tiyazol türevleri.
PE20020753A1 (es) Heteroaromaticos fusionados como activadores de la glucoquinasa
NO20061107L (no) CRF-antagonister og heterobrcykliske forbindelser
PE20090709A1 (es) Compuestos heterociclico de 5 miembros
PE20040581A1 (es) Inhibidores heterociclicos de cinasas
NO178067C (no) Analogifremgangsmåte til fremstilling av terapautisk aktive heterocykliske forbindelser
PE20080404A1 (es) Derivados bencil-amino-piperidina como inhibidores de cetp
TR200201752T2 (tr) Dipeptid nitril katepsin K inhibitörleri.
PE20020509A1 (es) Aza y poliaza-naftalenil carboxamidas utiles como inhibidores de la integrasa del vih
PE20080843A1 (es) Inhibidores de renina y metodo para su utilizacion
TW200800949A (en) Macrocylic inhibitors of hepatitis C virus
EA200401381A1 (ru) 3-гетероарилзамещённые изоксазолины
TR200102805T2 (tr) Glikokinaz aktivatörleri
KR950704304A (ko) 이환식 헤테로환 함유 술폰아미드 및 술폰산 에스테르 유도체(bicyclic heterocyclic sulfonamide and sulfonic ester derivatives)
EA200800477A1 (ru) Макроциклические ингибиторы вируса гепатита с
PE20080706A1 (es) Arilmidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
PE20110294A1 (es) Compuestos heterociclicos como inhibidores de enzimas de senal especifica
DK200001556A (da) Substituerede thiazolidindionderivater
PE20030007A1 (es) Inhibidores de aldosa reductasa del grupo de las piridazinonas
TW200745118A (en) Macrocylic inhibitors of hepatitis C virus
PE20090610A1 (es) Derivados de pirazol sustituidos
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
PE20041078A1 (es) Derivados heterociclicos inhibidores de la elastasa leucocitica humana (elh)
PE20001419A1 (es) COMPLEJO DEL INHIBIDOR DE RAS-FARNESILTRANSFERASA Y SULFOBUTILETER-7-ß-CICLODEXTRINA O 2-HIDROXIPROPIL-ß-CICLODEXTRINA Y METODO

Legal Events

Date Code Title Description
FC Refusal